Sherlock said in 2,000 tests it ran before the FDA granted emergency use authorization, there were no false negatives. Pictured, left to right: Sherlock Biosciences cofounders Omar Abudayyeh, Jonathan Gootenberg, Rahul Dhanda, Jim Collins and Pardis Sabeti
{}